150 related articles for article (PubMed ID: 10092986)
41. Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine.
Wei N; Liu R; Ou Y; Li X; Qiang O; Guo W; Tang CW
World J Gastroenterol; 2011 Oct; 17(39):4434-9. PubMed ID: 22110271
[TBL] [Abstract][Full Text] [Related]
42. Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor.
Seydel AS; Miller JH; Sarac TP; Ryan CK; Chey WY; Sax HC
Am J Surg; 1996 Sep; 172(3):267-71. PubMed ID: 8862081
[TBL] [Abstract][Full Text] [Related]
43. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel.
Medhus AW; Bondi J; Gaustad P; Husebye E
Aliment Pharmacol Ther; 2000 Feb; 14(2):233-40. PubMed ID: 10651665
[TBL] [Abstract][Full Text] [Related]
44. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
[TBL] [Abstract][Full Text] [Related]
45. Effects of subtotal colectomy on bacterial translocation during experimental acute pancreatitis.
van Minnen LP; Nieuwenhuijs VB; de Bruijn MT; Verheem A; Visser MR; van Dijk JE; Akkermans LM; Gooszen HG
Pancreas; 2006 Jan; 32(1):110-4. PubMed ID: 16340752
[TBL] [Abstract][Full Text] [Related]
46. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
[TBL] [Abstract][Full Text] [Related]
47. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.
Zhang SC; Wang W; Ren WY; He BM; Zhou K; Zhu WN
World J Gastroenterol; 2003 Mar; 9(3):534-8. PubMed ID: 12632513
[TBL] [Abstract][Full Text] [Related]
48. Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs.
Cowles VE; Nellans HN; Seifert TR; Besecke LM; Segreti JA; Mohning KM; Faghih R; Verlinden MH; Wegner CD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1106-11. PubMed ID: 10869416
[TBL] [Abstract][Full Text] [Related]
49. Ghrelin abates bacterial translocation following burn injury by improving gastric emptying.
Sallam HS; Urvil P; Savidge TC; Chen JDZ
Neurogastroenterol Motil; 2020 Feb; 32(2):e13742. PubMed ID: 31603615
[TBL] [Abstract][Full Text] [Related]
50. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms.
Di Lorenzo C; Lucanto C; Flores AF; Idries S; Hyman PE
J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):508-12. PubMed ID: 9822313
[TBL] [Abstract][Full Text] [Related]
51. Does octreotide impair anastomotic healing after small bowel resection?
Papalambros E; Filis K; Angelopoulou R; Diamantis T; Tsigris C; Bastounis E
Acta Chir Belg; 2004 Apr; 104(2):198-203. PubMed ID: 15154579
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
[TBL] [Abstract][Full Text] [Related]
53. Treatment of acute postoperative ileus with octreotide.
Cullen JJ; Eagon JC; Dozois EJ; Kelly KA
Am J Surg; 1993 Jan; 165(1):113-9; discussion 119-20. PubMed ID: 8418686
[TBL] [Abstract][Full Text] [Related]
54. Effect of octreotide on enteric motor neurons in experimental acute necrotizing pancreatitis.
Zhou H; Gao J; Zou D; Wu W; Li Z
PLoS One; 2012; 7(12):e52163. PubMed ID: 23300603
[TBL] [Abstract][Full Text] [Related]
55. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
[TBL] [Abstract][Full Text] [Related]
56. The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial.
Wilkinson NW; Gustafson RJ; Frizzi JD
Obes Surg; 2002 Dec; 12(6):765-72. PubMed ID: 12568180
[TBL] [Abstract][Full Text] [Related]
57. Difference between the antisecretory mechanisms of opioids and the somatostatin analogue octreotide in cholera toxin-induced small intestinal secretion in the rat.
Sjöqvist A
Regul Pept; 1992 Aug; 40(3):339-49. PubMed ID: 1438979
[TBL] [Abstract][Full Text] [Related]
58. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.
Chander Roland B; Garcia-Tsao G; Ciarleglio MM; Deng Y; Sheth A
J Clin Gastroenterol; 2013; 47(10):888-93. PubMed ID: 23632359
[TBL] [Abstract][Full Text] [Related]
59. [Effect of octreotide on gastric and duodenal motility].
Okamoto E; Haruma K; Hatake J; Fujimura J; Yamanaka H; Tani H; Futagami Y; Tsuga K; Shimatani T; Tanaka N
J Smooth Muscle Res; 1995 Dec; 31(6):364-7. PubMed ID: 8867933
[No Abstract] [Full Text] [Related]
60. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
